Summary
Highlights
Humoral immunity relies on antibodies, proteins made by special white blood cells, to combat viruses and bacteria in bodily fluids. This system is responsible for long-term immunity against diseases like mumps and is the basis for how vaccinations work.
The adaptive immune system steps in when the innate system is overwhelmed. Unlike the innate system, it must be introduced to a pathogen before attacking and remembers past threats, leading to a stronger and faster secondary response. It operates systemically, deploying humoral and cellular defenses.
The immune system identifies foreign substances through antigens, which are large signaling molecules not normally found in the body. B lymphocytes, maturing in the bone marrow, develop immunocompetence to recognize antigens and self-tolerance to avoid attacking the body's own cells. Each B cell has unique membrane-bound antibodies.
When a B cell encounters its specific antigen, it activates, cloning itself into effector (plasma) cells and long-lived memory cells. Plasma cells become antibody factories, mass-producing specific antibodies to fight the invader. Memory cells ensure a faster and stronger response upon future encounters with the same antigen, explaining the effectiveness of vaccinations.
Antibodies don't directly kill pathogens but neutralize them by blocking binding sites on viruses or toxins. They can also cause agglutination, clumping antigens together for easier phagocytosis by macrophages, and call in other immune cells to destroy antigen-antibody complexes.
Active humoral immunity occurs when B cells encounter antigens and produce antibodies. This can happen naturally (e.g., catching the flu) or artificially through vaccination. Vaccines introduce weakened or dead pathogens to prime the immune system for a robust secondary response, providing critical protection against various diseases.
Passive humoral immunity involves receiving pre-made antibodies. Babies acquire natural passive immunity from their mothers through the placenta and breast milk. Artificial passive immunity can be obtained by receiving antibodies from an immune donor, offering temporary protection, as seen in some Ebola treatments, allowing the body crucial time to develop its own active immunity.
While B cells and antibodies are crucial, some pathogens hide inside cells, evading the humoral response. The next episode will explore cellular immunity, which tackles these intracellular threats, concluding the discussion on the adaptive immune system's battle strategies.